122 related articles for article (PubMed ID: 27495224)
1. Peripheral Proinsulin Expression Controls Low-Avidity Proinsulin-Reactive CD8 T Cells in Type 1 Diabetes.
Thayer TC; Pearson JA; De Leenheer E; Hanna SJ; Boldison J; Davies J; Tsui A; Ahmed S; Easton P; Siew LK; Wen L; Wong FS
Diabetes; 2016 Nov; 65(11):3429-3439. PubMed ID: 27495224
[TBL] [Abstract][Full Text] [Related]
2. Proinsulin Expression Shapes the TCR Repertoire but Fails to Control the Development of Low-Avidity Insulin-Reactive CD8+ T Cells.
Pearson JA; Thayer TC; McLaren JE; Ladell K; De Leenheer E; Phillips A; Davies J; Kakabadse D; Miners K; Morgan P; Wen L; Price DA; Wong FS
Diabetes; 2016 Jun; 65(6):1679-89. PubMed ID: 26953160
[TBL] [Abstract][Full Text] [Related]
3. Differentiating MHC-Dependent and -Independent Mechanisms of Lymph Node Stromal Cell Regulation of Proinsulin-Specific CD8
Thayer TC; Davies J; Pearson JA; Hanna SJ; Wen L; Wong FS
Diabetes; 2021 Feb; 70(2):529-537. PubMed ID: 33122391
[TBL] [Abstract][Full Text] [Related]
4. APC-targeted proinsulin expression inactivates insulin-specific memory CD8
Reeves PL; Rudraraju R; Liu X; Wong FS; Hamilton-Williams EE; Steptoe RJ
Immunol Cell Biol; 2017 Oct; 95(9):765-774. PubMed ID: 28611473
[TBL] [Abstract][Full Text] [Related]
5. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide.
Martinez NR; Augstein P; Moustakas AK; Papadopoulos GK; Gregori S; Adorini L; Jackson DC; Harrison LC
J Clin Invest; 2003 May; 111(9):1365-71. PubMed ID: 12727928
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic alterations in pancreatic lymph node stromal cells from human donors with type 1 diabetes and NOD mice.
Postigo-Fernandez J; Farber DL; Creusot RJ
Diabetologia; 2019 Nov; 62(11):2040-2051. PubMed ID: 31486854
[TBL] [Abstract][Full Text] [Related]
7. Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes.
Chen W; Bergerot I; Elliott JF; Harrison LC; Abiru N; Eisenbarth GS; Delovitch TL
J Immunol; 2001 Nov; 167(9):4926-35. PubMed ID: 11673498
[TBL] [Abstract][Full Text] [Related]
8. Antigen presenting cell-targeted proinsulin expression converts insulin-specific CD8
Reeves PLS; Rudraraju R; Wong FS; Hamilton-Williams EE; Steptoe RJ
Eur J Immunol; 2017 Sep; 47(9):1550-1561. PubMed ID: 28665492
[TBL] [Abstract][Full Text] [Related]
9. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.
Nakayama M; Abiru N; Moriyama H; Babaya N; Liu E; Miao D; Yu L; Wegmann DR; Hutton JC; Elliott JF; Eisenbarth GS
Nature; 2005 May; 435(7039):220-3. PubMed ID: 15889095
[TBL] [Abstract][Full Text] [Related]
10. Altered Gut Microbiota Activate and Expand Insulin B15-23-Reactive CD8+ T Cells.
Pearson JA; Kakabadse D; Davies J; Peng J; Warden-Smith J; Cuff S; Lewis M; da Rosa LC; Wen L; Wong FS
Diabetes; 2019 May; 68(5):1002-1013. PubMed ID: 30796028
[TBL] [Abstract][Full Text] [Related]
11. IL-21 regulates SOCS1 expression in autoreactive CD8
Sutherland APR; Graham KL; Papadimitriou M; Jhala G; Trivedi P; Catterall T; Fynch S; Kay TWH; Thomas HE
Sci Rep; 2019 Oct; 9(1):15302. PubMed ID: 31653894
[TBL] [Abstract][Full Text] [Related]
12. Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes.
Wong FS; Siew LK; Scott G; Thomas IJ; Chapman S; Viret C; Wen L
Diabetes; 2009 May; 58(5):1156-64. PubMed ID: 19208910
[TBL] [Abstract][Full Text] [Related]
13. Immunotargeting of insulin reactive CD8 T cells to prevent diabetes.
Scott GS; Fishman S; Khai Siew L; Margalit A; Chapman S; Chervonsky AV; Wen L; Gross G; Wong FS
J Autoimmun; 2010 Dec; 35(4):390-7. PubMed ID: 20850948
[TBL] [Abstract][Full Text] [Related]
14. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
[TBL] [Abstract][Full Text] [Related]
15. Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice.
Levisetti MG; Lewis DM; Suri A; Unanue ER
Diabetes; 2008 Jul; 57(7):1852-60. PubMed ID: 18398138
[TBL] [Abstract][Full Text] [Related]
16. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
[TBL] [Abstract][Full Text] [Related]
17. Perinatal tolerance to proinsulin is sufficient to prevent autoimmune diabetes.
Jhala G; Chee J; Trivedi PM; Selck C; Gurzov EN; Graham KL; Thomas HE; Kay TW; Krishnamurthy B
JCI Insight; 2016 Jul; 1(10):e86065. PubMed ID: 27699217
[TBL] [Abstract][Full Text] [Related]
18. Identification of Candidate Tolerogenic CD8(+) T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model.
Yu C; Burns JC; Robinson WH; Utz PJ; Ho PP; Steinman L; Frey AB
J Diabetes Res; 2016; 2016():9083103. PubMed ID: 27069933
[TBL] [Abstract][Full Text] [Related]
19. Insulin-producing intestinal K cells protect nonobese diabetic mice from autoimmune diabetes.
Mojibian M; Lam AW; Fujita Y; Asadi A; Grassl GA; Dickie P; Tan R; Cheung AT; Kieffer TJ
Gastroenterology; 2014 Jul; 147(1):162-171.e6. PubMed ID: 24662331
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells in human thymus and periphery display a proinsulin epitope in a transcription-dependent, capture-independent fashion.
Garcia CA; Prabakar KR; Diez J; Cao ZA; Allende G; Zeller M; Dogra R; Mendez A; Rosenkranz E; Dahl U; Ricordi C; Hanahan D; Pugliese A
J Immunol; 2005 Aug; 175(4):2111-22. PubMed ID: 16081777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
